Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) Equity Average (2023 - 2025)

Historic Equity Average for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to $63.4 million.

  • Connect Biopharma Holdings' Equity Average changed N/A to $63.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.4 million, marking a year-over-year change of. This contributed to the annual value of $96.8 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Connect Biopharma Holdings reported Equity Average of $63.4 million as of Q3 2025.
  • Over the past 5 years, Connect Biopharma Holdings' Equity Average peaked at $115.1 million during Q4 2023, and registered a low of $63.4 million during Q3 2025.